| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Doxepin | Doxepin EP Impurity A | VL2860003 | View CAS 4504-87-4 |
| Doxepin | Doxepin EP Impurity B | VL2860004 | View CAS 4504-88-5 |
| Doxepin | Doxepin EP Impurity C | VL2860005 | View CAS 4504-96-5 |
| Doxepin | Doxepin EP Impurity D | VL2860002 | View CAS 25127-31-5 |
| Doxepin | Doxepin N-Oxide | VL2860001 | View CAS 22684-91-9 |
| Catalogue No. | VL2860001 |
| CAS No. | 22684-91-9 |
| Molecular Formula | C₁₉H₂₁NO₂ |
| Molecular Weight | 295.38 |
| Parent drug | Doxepin |
| IUPAC Name | 3-Dibenz[b, e]oxepin-11(6H)-ylidene-N, N-dimethyl-1-propanamine N-Oxide |
| Synonyms | N/A |
| References | "Holm, René, and David P. Elder. “Analytical Advances in Pharmaceutical Impurity Profiling.” European Journal of Pharmaceutical Sciences, vol. 87, May 2016, pp. 118–35, https://doi.org/10.1016/j.ejps.2015.12.007. ?" |
| Status | In-stock |
| ListName | Doxepin N-Oxide |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
